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The quality of follicular oocytes depends on interactions with surrounding granulosa cells. Development of molecular techniques
and methods enables better understanding of processes underlying mammalian reproduction on cellular level. The success in
reproductive biology and medicine in different species depends on reliable assessment of oocyte and embryo viability which
presently mainly bases on embryo morphology. Although successful pregnancies have been achieved using this approach, its
precision still should be improved and completed with other, more objective, and accurate assessment strategies. Global profiling
of gene expression in follicular cumulus cells using microarrays is continuously leading to the establishment of new biomarkers
which can be used to select oocytes with highest developmental potential. Even more potential applications and greater precision
could be achieved using next generation sequencing (NGS) of granulosa and cumulus cell RNA (RNA-seq). However, due to the
high cost, this method is not used as frequently as microarrays at the moment. In any case, high-throughput technologies offer
the possibilities and advantages in ovarian somatic cell analysis on scale that has not been noted so far. The aim of this work is to
present current directions and examples of global molecular profiling of granulosa cells and underline its impact on reproductive
biology and medicine.
1. Introduction
Follicles in mammalian ovaries undergo regular changes
including recruitment, expansion, maturation, rupture,
development into corpus luteum, and final atresia. All those
processes are controlled by gonadotropins secreted from the
pituitary which administrate signaling networks between
the oocyte and the somatic cells in the ovary. Two somatic
cell types can be distinguished in the follicle: the mural
granulosa cells lying on the basal membrane of the follicular
wall and cumulus granulosa cells (CCs) surrounding oocyte.
These cells have common origin at early follicular stage
but differentiate into two subpopulations in the course
of follicular development, up to the preovulatory stage.
Cumulus cells stay close to the oocyte forming gap junction
projections which allow transport of metabolites between
the somatic cells and the oocyte.The oocyte secretes different
signaling factors that control and influence proliferation and
the differentiation of cumulus cells (Figure 1). Oocyte and
cumulus cells form the cumulus-oocyte complex (COC) that
remains intact during ovulation up to fertilization. Mural
granulosa cell layer remains in less tight contact with oocyte
due to the distance and is responsible for the steroidogenic
activity of thematuring follicle. Mural granulosa cells express
receptors for LH necessary for triggering the final maturation
of the follicle and ovulation [1, 2].
The advent and development of “omics” field, such as
genomics, transcriptomics, proteomics, and metabolomics,
is continuously changing our understanding of mammalian
physiology and approaches towards solving particular health
problems [3]. In addition to studies aiming at better under-
standing of basis and processes of mammalian folliculogen-
esis, increasing interest and significance of high-throughput
techniques such as microarrays, next generation sequencing,
or single cell genomics is also observed in reproductive
medicine to evaluate quality of oocytes and embryos [4].
Transcriptome is the RNA content of the cell [3] while
transcriptomics relates to study of transcriptomes and their
functions. It serves as a tool to analyse a large number of genes
in parallel and bases on assumption that genes involved in
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Figure 1: Schematic illustration of mutual interactions (via
paracrine growth factors) between somatic cells and oocyte in
ovarian follicles (T: theca cell layer, MG: mural granulosa cell layer,
C: cumulus cells, and O: oocyte).
specific processes are expressed together and genes showing
similar expression patterns may be functionally linked and
regulated by similar genetic control mechanisms. Patterns of
gene expression levels deliver information about functional
status of the cell [5].
The basic and most widely used approach for transcrip-
tome analysis is microarray hybridization. Currently, several
microarray systems are used among which Affymetrix and
Illumina platforms are the most popular ones. Illustration of
main steps of granulosa cell RNA preparation for microarray
analysis is presented in Figure 2.
Next generation sequencing (NGS) is an alternative
approach to study qualitative and quantitative RNA content
of the cells (RNA-seq). NGS delivers huge amount of data
which, after bioinformatic analysis, can be translated into
biological knowledge. Although the cost of NGS analysis has
been significantly reduced in recent years, it is still consid-
erable which limits application of this technology in routine
clinical practice. Nevertheless, this method is being increas-
ingly used in research. It is assumed that NGS, not microar-
rays, will be the basic tool for genomic and transcriptomic
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Figure 2: Schematic illustration of preparation of RNA isolated
from granulosa cells for transcriptome analysis.
analysis in the future as its potential to deliver biologically
relevant information ismuch greater than in case of approach
based on chips.
In this work, current applications, directions, and exam-
ples of using high-throughput technologies for investigation
of ovarian granulosa cell transcriptome are presented.
2. Transcriptomic Analysis of
Granulosa Cells to Determine Factors
Involved in Follicular Development
Large number of studies have been carried out to identify
the mechanisms controlling folliculogenesis. Early folliculo-
genesis (from follicle formation of the resting pool to the
preantral stage) is particularly important as it affects and
regulates the size of the resting primordial follicle pool and
the fate of the follicles, which in turn influences reproductive
life span and fertility [1, 2]. Ovarian follicle is a mixture of
different cell types. Cell-specific gene expression driving early
folliculogenesis is still not completely known. To elucidate
the drive factors of follicular development Bonnet et al. [6]
successfully developed laser capture microdissection (LCM)
technique coupled with microarray to isolate and investigate
very small sized follicles from sheep ovary. Such approach
ensured pure cell populations (granulosa cells and oocytes),
the transcriptome of which was profiled using bovine chip.
The study revealed 1050 transcripts specific to the granulosa
cells and 759 specific to the oocyte (comparison of oocyte
versus follicular cell transcriptomes). This work, for the
first time, demonstrated the global gene expression pattern
in specific follicular compartments using high-throughput
technology. Obtained data were basis for functional analysis
related to processes critical for early folliculogenesis.
To determine crucial factors regulating the gonadotropin-
independent and -dependent follicle growth stage and to
facilitate development of a culture system for early growing
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follicles, DNA microarray analysis of mouse ovaries recov-
ered at 7, 10, 13, 16, and 19 days of age was performed [7].This
study showed strong intensity of zona pellucida glycopro-
teins, bone morphogenic protein-15 (BMP-15), and growth
differentiation factor (GDF-9) in 7-day-old mice, which
gradually declined in 19-day-old mice. KIT, KIT ligand, anti-
Mu¨llerian hormone (AMH), and platelet-derived growth fac-
tor (PDGF), which are secreted by granulosa cell secreted fac-
tors, also showed relatively high expression. This work con-
tributed to the understanding of factors involved in follicular
development and this knowledge may be used for establish-
ment of new in vitro systems for the culture of follicles with
potential medical application in severely affected patients.
Using The NimbleGen platform with high-density
expression arrays, Batista et al. [8] compared the transcrip-
tomes of granulosa-like cells overexpressing, or not, FOXL2,
one of the earliest ovarian markers which, together with its
targets, can serve as a model to study ovarian development
and function in normal and pathological conditions. It was
demonstrated that mediators of inflammation, apoptotic
and transcriptional regulators, genes involved in cholesterol
metabolism, and genes encoding enzymes, and transcription
factors involved in reactive oxygen species detoxification
were upregulated. On the other hand, the transcription of
genes involved in proteolysis, signal transduction as well as in
transcription regulation was shown to be down-regulated by
FOXL2. Potential target promoters activated and repressed
by FOXL2 were discriminated by bioinformatic analysis.
Using genome-wide analysis of DNAmicroarray data sets
based on samples from periovulatory ovaries, Kawamura et
al. [9] found increases in natriuretic peptide precursor type
C (NPPC-gene encoding C-type natriuretic peptide, CNP)
transcripts in granulosa cells during preovulatory follicle
growth in mice and a rapid decline induced by the preovu-
latory LH/hCG stimulation. Ovarian CNP content was
decreased upon treatment of preovulatory animals with hCG.
NPPC mRNA was predominantly expressed in mural granu-
losa cells exhibiting similar regulation following gonado-
tropin treatment, in isolated ovarian cells.
Bonnet et al. [10] identified the genes differentially
expressed in pig granulosa cells in the course of the terminal
ovarian follicle growth, to obtain a comprehensive view
of these mechanisms. In the first step, specific microarray
was developed using cDNAs from suppression subtractive
hybridization libraries (345 contigs) obtained by comparison
of three follicle size classes: small, medium, and large antral
healthy follicles. In the next step, a transcriptomic analysis
using cDNA probes from these three follicle classes identified
differentially expressed transcripts along the terminal follic-
ular growth and genes predictive of size classes (Table 1). The
data analysis allowed identifying gene networks important for
terminal follicular development.
In order to elucidate the differentiation status and respon-
siveness to gonadotropin stimulation in ER𝛽-null mice,
recently, Binder et al. [11] isolated preovulatory granulosa
cells from wild-type and ER𝛽-null mice using laser capture
microdissection. The aim was to examine the genomic tran-
scriptional response downstream of pregnant mare serum
gonadotropin (mimicking FSH) and pregnant mare serum
gonadotropin/human chorionic gonadotropin (mimicking
LH) stimulation. This approach allowed a comparison of in
vivo granulosa cells at the same stage of development from
both wild-type and ER𝛽-null ovaries. ER𝛽-null granulosa
cells showed altered expression of genes known to be regu-
lated by FSH (Akap12 and Runx2) as well as not previously
reported (Arnt2 and Pou5f1) in wild-type granulosa cells.The
analysis also identified more than 300 genes not previously
associated with ER𝛽 in granulosa cells (Table 1).
Small RNAs including microRNAs (miRNAs) are now
considered as important regulators of follicular development
[20]. Using small RNA sequencing (small RNA-seq) Velthut-
Meikas et al. [21] determined the miRNA profile of the
two intrafollicular somatic cell types: mural and cumulus
granulosa cells isolated from women undergoing controlled
ovarian stimulation and in vitro fertilization. In total, 936
annotated and 9 novel miRNAs were identified. Ninety of
the annotated miRNAs were differentially expressed between
mural granulosa cells and cumulus cells. Bioinformatic anal-
ysis revealed that TGF𝛽, ErbB signaling, and heparan sulfate
biosynthesis were targeted by miRNA in both granulosa cell
populations, while extracellularmatrix remodeling,Wnt, and
neurotrophin signaling pathways were targeted by a miRNA
in mural granulosa cells.
3. Transcriptomic Analysis of Granulosa Cells
to Evaluate Oocyte and Embryo Quality
The fact that cumulus cells are in close communication with
oocyte via gap junctions and local paracrine factors suggests
that their analysis may give reliable information about the
oocyte itself. Cumulus cells can be easily collected without
compromising the oocyte, which makes them attractive
targets for studies on noninvasive biomarkers of oocyte
developmental competence [4].
Gene expression profiling of mural rat granulosa cells
with Affymetrix rat whole genome array revealed that the
most differentially expressed gene, lysyl oxidase, may be a
candidate biomarker of oocyte health and can be used for
the selection of good quality oocytes for reproductive biology
procedures [13] (Table 1).
Using microarrays Assidi et al. [15] aimed at identifying
markers of oocyte competence that are expressed in bovine
cumulus cells. Candidate genes expressed in cumulus cells
which could be valuable and indirect markers of oocyte
competence were hyaluronan synthase 2 (HAS2), inhibin
betaA (INHBA), epidermal growth factor receptor (EGFR),
gremlin 1 (GREM1), betacellulin (BTC), CD44, tumor necro-
sis factor-induced protein 6 (TNFAIP6), and prostaglandin-
endoperoxide synthase 2 (PTGS2). These biomarkers were
proposed to be potential candidates to predict oocyte com-
petence and to select higher-quality embryos for transfer
(Table 1). Using bovinemodel Bettegowda et al. [14] identified
differences in RNA transcript abundance in cumulus cells
harvested from oocytes of adult versus prepubertal animals
(characterized by poor oocyte quality) by microarray anal-
ysis. It was revealed that four genes encoding for the lyso-
somal cysteine proteinases cathepsins B, S, and Z displayed
greater transcript abundance in cumulus cells surrounding
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Table 2: Gene expression profiling of human granulosa and cumulus cells.
Type of cell Assay Gene profiles/outcome Reference
Granulosa cells from
aspirated follicular fluid Microarray
FDX1, CYP19A1, CDC42,
SERPINE2, and 3bHSD1, positively
correlated with oocyte
developmental competence
Hamel et al., 2008 [16]
Cumulus cells
Whole Human Genome Oligo
Microarray 4x44K (Agilent
Technologies)
RGS2, related to oocyte
developmental competence Feuerstein et al., 2012 [17]
Cumulus cells Affymetrix HG-U133 Plus 2.0array
BCL2L11, PCK1, and NFIB,
significantly correlated with embryo
potential
Assou et al., 2008 [18]
Cumulus cells from
gonadotropin stimulated
patients
Human Genome U133 Plus 2.0
microarrays
NPY1R, GM2A, GREM1 OSBPL6,
STC2, and PTX3, correlated with
embryo quality
Assou et al., 2013 [19]
oocytes harvested from prepubertal animals. Functional
analysis indicated the role for cumulus cell cathepsins in
compromised oocyte competence and resulted in conclusion
that cumulus cell cathepsin transcript abundance may be
predictive of oocyte quality (Table 1).
These close relations between oocyte and cumulus cells
are of particular significance in assisted reproduction proce-
dure. Single embryo transfer is considered the most appro-
priate way to reduce the frequency of multiple pregnancies
following in vitro fertilisation.However, selecting the embryo
for single transfer embryo with the highest chances of preg-
nancy remains a difficult challenge since morphological and
kinetics criteria provide poor prediction of both developmen-
tal and implantation ability. The oocyte-cumulus interaction
through the expression of specific genes helps the oocyte
to acquire its developmental competence. Using microarrays
Feuerstein et al. [17] attempted to determine genes related
to oocyte developmental competence. Gene expression of
oocytecumuluswas studied according to the nuclearmaturity
of the oocyte (immature versus mature oocyte) and to the
developmental competence of the oocyte (ability to reach
the blastocyst stage after fertilisation). Microarray analysis
data delivered 308 differentially expressed genes out of which
8 genes were selected according to oocyte developmental
competence for further validation. Three of these 8 selected
genes were validated as potential biomarkers (PLIN2, RGS2,
and ANG). Finally, RGS2, known as a regulator of G protein
signalling, was the only gene among selected candidates
biomarkers of oocyte competence which covered many fac-
tors of variability (Table 2).
Using human Genome U133 Plus 2.0 microarrays Ouan-
daogo et al. [22] performed an analysis of the genes expressed
in human cumulus cells obtained from patients undergoing
intracytoplasmic sperm injection. Cumulus cells samples
were isolated from oocyte at germinal vesicle, stage meta-
phase I, and stage metaphase II. Differentially over-expressed
genes between the three cumulus cells categories were identi-
fied. The mentioned study demonstrated a specific signature
of gene expression in cumulus cells obtained from MII
oocyte compared with germinal vesicle and metaphase I.
As concluded by the authors gene expression profile, which
is specific of MII mature oocyte, may be used as predictor
of oocyte quality. Although the study failed to list spe-
cific markers of oocyte quality, it anyway underlined the
distinct gene signature of individual CC samples isolated
from oocytes at different stages of development. To assess
such signatures is a first necessary step to qualify the cumulus
cell status as competent or incompetent.
As the maturation conditions of human cumulus-oocyte
complexes might affect gene expression in both oocyte and
cumulus cells Ouandaogo et al. [23] compared the transcrip-
tome profiles of cumulus cells isolated from in vivo and in
vitro matured COC at different nuclear maturation stages. In
this study microarray technology was used used to analyse
the global gene expression to compare the expression profiles
of CCs from COC at different nuclear maturation stages fol-
lowing IVMor in vivomaturation. Afterwards, selected genes
were validated by qPCR. It was found out that, in CCs isolated
after IVM, genes related to cumulus expansion and oocyte
maturation, such as EREG, AREG, and PTX3, were down-
regulated, while cell cycle-related genes were upregulated in
comparison with CCs from in vivo matured COC from poly-
cystic ovary syndrome and normal responder patients. Using
Affymetrix Gene Chip Mouse Genome 430 2.0 array Kind et
al. [24] observed that 1593 genes were differentially expressed,
with 811 genes upregulated and 782 genes downregulated in
mouse IVMcomparedwith IVVcumulus cells; selected genes
were validated by real-time reverse transcription-polymerase
chain reaction.
Using DNA microarrays Haouzi et al. [25] studied the
LH/hCGR gene expression in cumulus cells surrounding
oocytes in patients undergoing controlled ovarian hyper-
stimulation (COS) before ICSI and related it to other ovar-
ian hyperstimulation quality parameters. The transcriptome
analysis of CC indicated a variable expression of LH/hCGR
among the patients and intrapatients. LH/hCGR mRNA
expression was negatively correlated with serum estradiol
level on the day of hCG administration. Eighty-five genes,
playing role mainly in steroid metabolism and in the ovula-
tion process (including TNFAIP6), were significantly modu-
lated between cumulus cells from patients with a high and
a low LH/hCGR expression. No significant differences in
6 BioMed Research International
LH/hCGR gene expression profile between COS protocols
were observed.
Recently, Assou et al. [19] characterized and compared
gene expression profiles in cumulus cells of periovulatory
follicles obtained from patients stimulated with HP-hMG
or rFSH in a GnRH antagonist cycle and studied their
relationshipwith in vitro embryo development, usingHuman
Genome U133 Plus 2.0 microarrays. Genes upregulated in
HP-hMG-treated CCs are involved in lipid metabolism
(GM2A) and cell-to-cell interactions (GJA5). On the other
hand, genes upregulated in rFSH-treated CCs play role in
cell assembly and organization (COL1A1 andCOL3A1). It was
demonstrated that some genes specific to each gonadotropin
treatment (NPY1R and GM2A for HP-hMG; GREM1 and
OSBPL6 for rFSH) were associated with day 3 embryo
quality and blastocyst grade at day 5, whereas others (STC2
and PTX3) were linked to in vitro embryo quality in both
gonadotropin treatments. Embryo and blastocyst quality
were assessed daily by the embryologists until 5 days after
oocyte retrieval. Top quality 8-cell embryos at day 3 were
subjected to blastocyst outcome analysis at day 5 (Table 2).
In study of Hamel et al. [16] hybridization data analysis
discriminated 115 genes associated with competent human
follicles (leading to a pregnancy). Selected candidates were
confirmed by Q-PCR: 3-beta-hydroxysteroid dehydrogenase
1, ferredoxin 1, serine (or cysteine) proteinase inhibitor clade
E member 2, cytochrome P450 aromatase, and cell division
cycle 42 (Table 2).
Global gene expression analysis performed by Vigone
et al. [12] showed that developmentally incompetent and
competent CCs share similar transcriptomes, with the excep-
tion of 422 genes, 97.6% of which were downregulated
in incompetent versus competent CSs.This demonstrated
that developmental incompetence or competence of antral
oocytes can be predicted using transcript markers expressed
by their surrounding CCs (i.e., Has2, Ptx3, Tnfaip6, Ptgs2,
and Amh) (Table 1). Using a combined microarray and
quantitative reverse-transcription polymerase chain reaction
approach Iager et al. [26] found a set of 12 genes predictive of
pregnancy outcome based on their expression levels in CCs.
Using microarrays, recently, Papler et al. [27] analyzed
surrounding mature oocytes that developed to morulae or
blastocysts on day 5 after oocyte retrieval. The analysis
revealed 66 differentially expressed genes between cumulus
cells of modified natural IVF and controlled ovarian hyper-
stimulation cycles. Further gene analysis showed that the
oxidation-reduction process, glutathione metabolic process,
xenobiotic metabolic process, and gene expression were sig-
nificantly enriched biological processes in modified natural
in vitro fertilization cycles. The study of Assou et al. [18]
showed that the expression of BCL2L11, PCK1, and NFIB
in CCs is significantly correlated with embryo potential and
successful pregnancy (Table 2).
4. Summary
Infertility is a civilization disease which affects a significant
number of couples of reproductive age. It is also a serious
medical and financial challenge which has been approached
for years with increasing efficiency and with application of
different methods and strategies. The progress in the field of
reproductive biology strongly depends on basic research and
better understanding of processes regulating follicular devel-
opment and oocyte maturation. This knowledge can be then
translated into clinical practice which enables solving of par-
ticular problems of fertility. As presented in this review, tran-
scriptomics is increasingly applied to the gamete and embryo
assessmentwhich leads to establishment of biomarkers linked
to oocyte and embryo quality. “The omics” offer much more
reliable and objective way to assess viability of oocytes and
embryos in comparison to conventional morphological eval-
uation. However, some problems related to the wide applica-
tion of these methods in clinical practice are still faced. Out
of them, duration of analysis and relatively high costs should
be mentioned as main obstacles. Therefore, a combination
of conventional morphological criteria of evaluation with
new, fast, inexpensive, easy-to-use, and noninvasive high-
throughput techniques is expected to ensure the progress
and efficiency of infertility diagnostics and treatment [3].
Development of high-throughput methods will also be bene-
ficial for solving fertility problems in patients suffering from
premature ovarian failure and ovarian impairment due to
adjuvant therapy for cancer. It also should be mentioned that
not only further achievements in the field of transcriptomics
but also proteomics (analysis of cell proteome) will be critical
for progress in reproductive biology and medicine.
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